Global market reach Leverage Lepu Medical's established overseas presence with three overseas subsidiaries and registrations in 40+ countries to expand distribution and accelerate entry into new regional markets, focusing on cardiovascular and interventional devices.

Diverse product footprint Capitalize on Lepu Medical’s broad portfolio spanning cardiovascular interventions, structural heart, neurointervention, rhythm management, anesthesia, diagnostics, and hemodialysis to cross-sell adjacent devices and win multi-product contracts with healthcare systems.

Regulatory momentum Target customers in regions where Lepu has CE certifications and FDA approvals (over 234 CE, 34 FDA) to shorten approval timelines, support faster market access, and position as a compliant supplier for hospital procurement.

Strategic partnerships Explore collaboration opportunities with Lepu’s R&D and manufacturing capabilities to co-develop next-gen devices or obtain joint venture access, leveraging their 4 in 1 platform strategy combining devices, pharma, services, and mobile health.

Competitive positioning Position against mid- to large-cap peers by emphasizing Lepu’s global listings, rapid expansion, and cost-efficient, high-quality innovation pipeline to deliver competitive value in cardiovascular and interventional care markets.